Massive Bio not only provides cancer patients with access to best practices, but also solves the pharmaceutical industry bottleneck for clinical trials and drug discovery, because 85% of US cancer patients are treated at community practices and are not readily accessible to clinical trials. Massive Bio translates the world class precision oncology knowledge of large cancer center experts, through a “virtual tumor board”, and then helps the patient and treating oncologist to operationalize these cancer expert recommendations at the point of care. Massive Bio can also facilitate bringing the patient to a large cancer center – if local treatment is not available. Massive Bio reduces the time, travel and cost burden for cancer patients. All the while, Massive Bio extracts intelligence from data through combination of clinical history, genomics and outcomes to improve current and future patient’s lives. Massive Bio supports cancer patients and their family members throughout their entire cancer journey.